Klinische studies dienst urologie

Bekijk het overzicht van de studies die op dit moment aangeboden kunnen worden aan patiënten met urologische tumoren en andere urologische problemen.

Blaas- en urinewegentumoren

EFFORT Trial

Phase II prospective trial to evaluate the impact of 18FFDG-PET-CT in stratifying patients with primary muscle invasive bladder cancer and adapting the treatment accordingly.

 

SINCERE Registry

Effect of a single instillation of Mitomycin C on the intravesical recurrence rate after ureteroscopy for Upper Tract Urothelial Carcinoma: A prospective, multicenter registry study. 

  • Inclusion criteria: All patients ≥ 18 years old with clinically non-metastatic UTUC planned for URS, either as a diagnostic or as treatment, followed by a SI-MMC (or any equivalent) are eligible for this study.
  • Local site Principal Investigator: dr. Carl Van Haute
  • More information: NCT05731622

 

Blaaspijnsyndroom

Er zijn momenteel geen studies beschikbaar.

 

Niertumoren

Er zijn momenteel geen studies beschikbaar.

 

Overactieve blaas

Er zijn momenteel geen studies beschikbaar.

 

Penistumoren

Er zijn momenteel geen studies beschikbaar.

 

Prostaattumoren

ARASTEP

A randomized, double-blind, placebo-controlled Phase 3 study of darolutamide plus androgen deprivation therapy (ADT) compared with placebo plus ADT in patients with high-risk biochemical recurrence (BCR) of prostate cancer

  • Inclusion criteria: High-risk BCR after RP followed by adjuvant RT or salvage RT or after RP in participants who are unfit for adjuvant RT or salvage RT or after Primary RT.  nmCSPC (adenocarcinoma) according to conventional imaging. PSADT < 12months.
  • Local site Principal Investigator: prof. dr. Steven Joniau.
  • Sub-investigator (Urology): dr. Alexander Giesen
  • More information: NCT05794906.

 

Testistumoren

Er zijn momenteel geen studies beschikbaar.

 

Urinaire incontinentie

COLD INDUCED

Diagnostic tool and therapeutic strategy for acute cold-induced urgency (ACIU) part 2: optimizing the protocol

  • Inclusion criteria: All patients with an overactive bladder for which a Urodynamic investigation is scheduled. Note that patients with prior pelvic floor surgery, neurological disorder or peripheral neuropathy are excluded from the study.
  • Local site Principal Investigator: prof. dr. Wouter Everaerts
  • Sub-investigator: prof. dr. Frank Van der Aa

 

Urinaire retentie

Er zijn momenteel geen studies beschikbaar.

 

Urineweg-infecties

MINUS Trial

Multicentric study on Infections of the Urinary tract after Stent removal

  • Inclusion criteria: Patients, 18 years of age and older who receive a ureteral stent during any endoscopic procedure will be approached to participate in the study
  • Local site Principal Investigator: dr. Carl Van Haute
  • Sub-investigator (Urology): prof. dr. Ben Van Cleynenbreugel
  • More information: NCT05329883

 

Questions

For more information, please contact trial urology.

Laatste aanpassing: 24 juni 2025